Related Experiment Video

Updated: Sep 17, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

Correlation between Visceral Adiposity Index (VAI) and Congestive Heart Failure (CHF) in patients with hypertension:

Ziyin Fan1, Li Yang1, Jia Song1

  • 1Department of Cardiology, Zhuzhou Central Hospital, No. 116, South Changjiang Road, Tianyuan District, Zhuzhou, Hunan, 412000, China.

BMC Cardiovascular Disorders
|July 3, 2025
PubMed

Insights

Visceral adiposity index (VAI) is linked to increased congestive heart failure (CHF) risk in hypertension patients. This study confirms VAI as an effective tool for assessing CHF risk in this population.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Public Health

Background:

  • Hypertension is a global health concern, closely associated with congestive heart failure (CHF).
  • Visceral adiposity index (VAI) is an emerging marker for visceral fat accumulation.

Purpose of the Study:

  • To investigate the correlation between visceral adiposity index (VAI) and the risk of congestive heart failure (CHF) in individuals with hypertension.
  • To evaluate the effectiveness of VAI in predicting CHF risk within the hypertensive population.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2018.
  • Employed weighted logistic regression, propensity score matching (PSM), and restricted cubic spline (RCS) analysis.
  • Conducted subgroup analyses based on sex, age, race, and comorbidities.

Main Results:

  • A significant positive correlation was observed between VAI and CHF risk in multivariable logistic regression (OR=1.15, 95% CI: 1.04, 1.29).
  • This association remained significant after PSM (OR=1.24, 95% CI: 1.06, 1.45) and exclusion of cardiovascular disease patients.
  • RCS analysis revealed a significant linear relationship between VAI and CHF risk (P=0.018).

Conclusions:

  • Visceral adiposity index (VAI) is a significant predictor of congestive heart failure (CHF) risk in patients with hypertension.
  • VAI serves as an effective tool for risk stratification of CHF in hypertensive individuals.
Abstract

Keywords:
Congestive heart failureCorrelationHypertensionVisceral adiposity index

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

217
Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy07:24

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

7.6K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
51
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
52
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
90
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
29
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
62